UCSF Adult Inpatient Susceptibility Data (Gram-Positives)1
R-testing not applicable to organism and should be considered resistant, AMP-ampicillin, CLIN-clindamycin, CTRX-ceftriaxone, DAP-daptomycin, DOX-doxycycline, LZD-linezolid, NAF-nafcillin, PCN-penicillin G, T/S-trimethoprim/sulfamethoxazole, VANC-vancomycin
Total isolates include floor isolates and ICU isolates from Parnassus, MB Adult, and MZ
Reported as % susceptible, tested from all sites except as indicated
|
Organism |
Total Isolates |
AMP/PCN2 |
CLIN |
CTRX |
DAP |
DOX |
LZD |
NAF |
T/S |
VANC |
|---|---|---|---|---|---|---|---|---|---|---|
|
Staphylococcus aureus |
916 |
N/A |
71 |
N/A |
100 |
85 |
99 |
72 |
95 |
99 |
|
MSSA |
672 |
N/A |
75 |
N/A |
100 |
92 |
100 |
99 |
97 |
100 |
|
MRSA |
266 |
N/A |
60 |
N/A |
100 |
66 |
99 |
N/A |
91 |
99 |
|
Staphylococcus epidermidis |
240 |
N/A |
57 |
N/A |
100 |
72 |
99 |
32 |
50 |
100 |
|
Staphylococcus lugdunesis |
52 |
N/A |
86 |
N/A |
100 |
90 |
100 |
78 |
96 |
100 |
|
Viridans group streptococci3 |
92 |
74 |
81 |
95 |
|
61 |
|
|
|
100 |
| Streptococcus anginosus group | 39 | 97 | 81 | 100 | 52 | 100 | ||||
|
Streptococcus mitis |
45 |
66 |
77 |
95 |
|
71 |
|
|
|
100 |
|
Enterococcus faecalis |
289 |
98 |
N/A |
N/A |
|
25 |
|
N/A |
N/A |
96 |
|
Enterococcus faecium |
182 |
11 |
N/A |
N/A |
984 |
18 |
96 |
N/A |
N/A |
39 |
1Adult inpatient susceptibilities include data from 1/1/2024 - 12/31/2024; 2Reflects ampicillin for Enterococcus spp & penicillin G for Streptococcus spp; 3Viridans group streptococci include S. anginosus, S. constellatus, S. intermedius, S. milleri, S. mitis, S. mutans, S. oralis, S. parasanguinis, S. salivarius, & S. sobrinus; 4Represents susceptible dose-dependent isolates only